Related Experiment Video
Updated: Jul 20, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active
Dorothy L Moore1, Wendy Vaudry, David W Scheifele
1Infectious Diseases Division, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada. dorothy.moore@muhc.mcgill.ca
Insights
Young children, including those previously healthy, are at significant risk for severe influenza illness and hospitalization. This study provides crucial baseline data on pediatric influenza cases before new immunization strategies were implemented.
Area of Science:
- Pediatric Infectious Diseases
- Public Health Surveillance
- Vaccinology
Background:
- Influenza is a frequent childhood infection necessitating hospitalization.
- Understanding pediatric influenza epidemiology is vital for public health interventions.
Purpose of the Study:
- Characterize children hospitalized with influenza and their disease manifestations.
- Establish baseline data on pediatric influenza before new immunization recommendations.
Main Methods:
- Retrospective chart review of 505 children hospitalized with laboratory-confirmed influenza.
- Data collected from 9 Canadian tertiary care hospitals during the 2003-2004 season.
Main Results:
- The majority of hospitalized children (57%) were under 2 years old; 58% were previously healthy.
- Common manifestations included fever and cough; serious complications like encephalopathy and myocarditis occurred.
- Only 7 of 154 eligible children were fully immunized before illness onset.
Conclusions:
- Healthy children and those with chronic conditions face risks from severe influenza.
- Continued surveillance is essential to assess the impact of evolving influenza immunization policies in children.
Objectives:
Influenza is a common childhood infection that may result in hospitalization. Our objectives were to (1) determine characteristics of children hospitalized for influenza and disease manifestations and (2) obtain baseline data before implementation of new recommendations for routine immunization of young children and their caretakers against influenza.
Methods:
All of the children hospitalized with laboratory-confirmed influenza at 9 Canadian tertiary care hospitals during the 2003-2004 influenza season were identified from virology laboratory reports, and their charts were reviewed.
Results:
There were 505 children admitted because of influenza. Fifty-seven percent were < 2 years old. Previously healthy children accounted for 58% of all of the cases. Pulmonary and neurologic disorders were the most common underlying chronic conditions. Fever and cough were the most frequent manifestations. Seizures occurred in 9% of cases. Serious complications included myocarditis (2), encephalopathy (6), and meningitis (1). There were 3 influenza-related deaths. Mean duration of hospitalization was 5.3 days. Twelve percent of children required ICU admission, and 6% required mechanical ventilation. Antibiotic therapy was administered in 77% of cases, and 7% received anti-influenza drugs. Information on influenza vaccination was available for 84 of 154 children identified as vaccine candidates. Twenty two had received vaccine, but only 7 children had been fully immunized > 14 days before the onset of illness.
Conclusions:
Healthy young children and children with chronic conditions are at risk for serious illness with influenza. Ongoing surveillance is needed to evaluate the impact of changing immunization recommendations on the burden of influenza illness in children.
Related Concept Videos
Influenza
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

